Lupin Limited announces the spin-off of its consumer healthcare division, LupinLife Consumer Healthcare Ltd., into a wholly ...

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

Pharmaceutical major Lupin Limited has announced the strategic spin-off of its consumer healthcare business, LupinLife ...

This is eligible for 180 days of generic drug exclusivity. The company will manufacture the product at its facility situated ...

Mumbai: Global pharma major Lupin Limited, has announced the strategic carve-out of its consumer healthcare business, ...

The product is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery.

The move is part of Lupin's broader strategy to create a specialised consumer healthcare entity, particularly aimed at ...

Lupin launches independent consumer healthcare entity to focus on India's self-care market, led by Anil Kaushal.

Auto majors Hyundai and Maruti Suzuki logged a 6% YoY dip in June sales. Lupin gained momentum with US FDA approval for its ...

Loteprednol Etabonate Ophthalmic Gel is bioequivalent to Lotemax SM Ophthalmic Gel of Bausch & Lomb Inc and will be ...